The Homeogenomic Trial

University of Washington

Status: Withdrawn

Conditions: Healthy

Treatments: Other: homeopathic remedy in 30C potency; Other: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT02018341

44817

Details and patient eligibility

About

A randomized double-blind placebo controlled homeopathic pathogenetic trial (HPT) will be carried out on 30 healthy adult volunteers. The remedy used for the proving will be administered in a potency of 30C. The remedy being used is a common homeopathic remedy commercially available in the US, but the exact remedy is not disclosed to participants.The purpose of the proving is twofold: 1) to determine if there is a difference in symptoms between those receiving an active versus placebo medicine, and 2) to see if there is a difference in gene expression between those who receive the homeopathic remedy or placebo. It is hypothesized that participants receiving the active medication will have more symptoms characteristic of the remedy and have specific patterns of gene expression in whole blood that are different from those in placebo recipients. Participants will record symptoms in a diary for 3 days prior to administration of study medications, during 3 day of its administration and for 3 days following completion of the study medication. Blood will be drawn for gene expression studies on the day that the study medication is started and again after taking the study medication for approximately 48 hours. An additional, optional blood draw for possible future analysis of gene expression will be done at the end of the study period.

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Read and Speak English

Exclusion criteria

• Acute illness in last 7 days
• Chronic illness requiring daily medication
• Use of homeopathic remedy within 4 weeks
• Use of homeopathic remedy of 200C potency in past 2 months
• Women who are pregnant or breastfeeding an infant

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

0 participants in 2 patient groups, including a placebo group

homeopathic remedy in 30C potency

Experimental group

Description:

5 lactose globules containing a commonly used homeopathic remedy in the potency of 30C will be administered twice daily for 3 days

Treatment:

Other: homeopathic remedy in 30C potency

placebo

Placebo Comparator group

Description:

5 lactose globules without any homeopathic remedy will be administered twice daily for 3 days

Treatment:

Other: Placebo